Spectral Medical (TSE:EDT) Trading 1.2% Higher - What's Next?

Key Points

• Spectral Medical's shares increased by 1.2%, trading at C$0.82, with a trading volume of 87,509 shares—a 45% rise from the average.
• The company has a market capitalization of C$326.25 million and reported a P/E ratio of -16.57, indicating potential challenges in profitability.
• Spectral Medical focuses on developing treatments for septic shock through its endotoxin activity assay (EAA) diagnostic and toraymyxin therapeutic.

Spectral Medical Inc. (TSE:EDT - )'s share price traded up 1.2% on Wednesday . The company traded as high as C$0.82 and last traded at C$0.82. 87,509 shares traded hands during trading, an increase of 45% from the average session volume of 60,538 shares. The stock had previously closed at C$0.81.

Spectral Medical Stock Performance

The stock's fifty day moving average price is C$0.83 and its two-hundred day moving average price is C$0.77. The company has a debt-to-equity ratio of 26.03, a quick ratio of 0.45 and a current ratio of 0.61. The company has a market cap of C$326.25 million, a P/E ratio of -16.57 and a beta of 0.96.

Spectral Medical Company Profile

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.